Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABPRO INC

NPI: 1154624799 · HARWOOD HEIGHTS, IL 60706 · Clinical Medical Laboratory · NPI assigned 12/20/2010

$3.19M
Total Medicaid Paid
231,609
Total Claims
161,952
Beneficiaries
105
Codes Billed
2018-01
First Month
2020-02
Last Month

Provider Details

Authorized OfficialLATINIK, ELLIOTT (PRESIDENT)
NPI Enumeration Date12/20/2010

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 183,270 $2.17M
2019 48,256 $1.02M
2020 83 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 20,508 10,932 $1.22M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 28,118 15,155 $951K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 7,309 4,433 $263K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 3,941 2,760 $106K
80321 5,187 3,131 $69K
80370 1,616 1,149 $63K
80348 9,013 6,244 $34K
80373 7,101 4,918 $32K
80361 11,425 8,379 $29K
80355 3,733 3,034 $23K
80337 439 247 $21K
80324 8,182 5,539 $20K
80368 755 530 $20K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 581 370 $19K
80366 3,271 2,640 $18K
80346 8,465 5,672 $17K
80354 7,924 5,499 $17K
80353 7,923 5,255 $17K
80358 7,069 4,788 $16K
80338 1,389 1,082 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,823 2,537 $13K
80356 10,960 7,873 $13K
80344 596 373 $12K
80365 8,910 6,272 $12K
80372 2,555 1,747 $11K
84443 Thyroid stimulating hormone (TSH) 2,373 2,122 $9K
80360 6,398 4,267 $9K
82607 1,958 1,866 $8K
80345 5,361 3,437 $8K
82746 1,763 1,684 $7K
80050 General health panel 776 729 $7K
80061 Lipid panel 2,946 2,621 $7K
80053 Comprehensive metabolic panel 3,049 2,650 $7K
80359 3,396 2,452 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 63 61 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 144 128 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 144 128 $5K
83550 1,751 1,671 $5K
83036 Hemoglobin; glycosylated (A1C) 2,462 2,239 $5K
80362 2,590 1,795 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,072 2,682 $5K
80369 2,008 1,567 $4K
80349 1,973 1,315 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 155 138 $4K
84480 1,200 1,152 $4K
83540 1,391 1,329 $4K
86141 213 200 $3K
84436 625 594 $3K
86038 940 904 $2K
84439 1,378 1,318 $2K
85651 1,355 1,273 $2K
84479 407 383 $2K
84550 1,333 1,280 $2K
82728 429 396 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 46 43 $2K
82533 131 124 $2K
83695 193 182 $2K
87086 Culture, bacterial; quantitative colony count, urine 344 312 $1K
83735 265 250 $1K
87481 53 51 $1K
82150 910 875 $1K
82550 222 207 $1K
86703 154 144 $949.96
86140 912 876 $933.03
86696 41 37 $720.21
81003 713 641 $658.05
84153 264 230 $631.39
36415 Collection of venous blood by venipuncture 2,061 1,518 $538.29
86695 41 37 $537.30
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 54 51 $520.35
82043 143 134 $418.29
86694 39 35 $410.56
83718 130 122 $323.52
86803 279 211 $258.83
84703 164 162 $253.24
86592 64 55 $235.58
84460 152 144 $230.78
84075 152 144 $223.72
84450 152 144 $223.72
83992 26 14 $220.00
84478 130 122 $218.61
82310 153 145 $214.18
82374 152 144 $213.43
81001 146 139 $211.15
82247 152 144 $209.98
84295 152 144 $207.98
82565 169 149 $205.58
84132 158 147 $204.65
82040 151 144 $203.70
82435 152 144 $200.15
85610 78 44 $190.15
82977 45 42 $189.85
82465 130 122 $170.94
82947 154 146 $165.32
84520 148 140 $162.32
84155 152 144 $160.10
87340 19 14 $151.02
80048 Basic metabolic panel (calcium, ionized) 55 55 $134.68
84702 19 17 $97.83
80074 18 14 $88.76
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 30 26 $50.22
80177 13 13 $36.94
88142 12 12 $31.98
80076 33 28 $8.69
80371 37 30 $0.00